Concepedia

Publication | Closed Access

Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes

DOI

31

Citations

0

References

2008

Year

Denise Serra, Y-L He, Julie Bullock, G-J Riviere, Sébastien Balez, S. Schwartz, Yuxiang Wang, Monica Ligueros‐Saylan, Venkateswar Jarugula, William P. Dole
International Journal of Clinical Pharmacology and Therapeutics

Abstract

Coadministration of vildagliptin with either glyburide or pioglitazone in patients with Type 2 diabetes improves postprandial glycemic control without notable effects on drug pharmacokinetics.